Pharmaceutical manufacturers of Lumefantrine

Shanghai Acebright Pharmaceuticals Group Co Ltd was established in 1996. Over 12 manufacturing facilities conforming to GMP standards are situated in China and India. The company specializes in a range of Vitamin products, ARV APIs & intermediates, and oncology APIs & finished pharmaceutical products. It serves as an integrated CDMO service partner from R&D to commercial manufacturing.

HELM AG, a company based in Hamburg and owned by a family, has a 120-year history in 4 diverse sectors: Pharmaceuticals, Chemicals, Crop Protection, and Crop Nutrition. With a global presence through subsidiaries, sales offices, and partnerships, HELM is recognized as one of the world's leading independent marketing firms for chemicals. At HELM Pharma, our goal is to establish ourselves as the top B2B project and marketing platform, offering a distinctive partnership experience. In the marketing of our products, we deliver a comprehensive range of services for our business associates.

Globela has been leading the way in innovation for almost seven decades. Originating in 2006 as a small pharmaceutical firm, Globela's current range of vertically integrated businesses is now concentrated on a variety of therapeutic areas including Gastroenterology, Cardiovascular, Diabetology, Oncology, Pain management, and Nephrology. A multinational company with EU GMP, WHO GMP, and ISO certifications, Globela also prides itself on its advanced research and development capability and high-quality compliant manufacturing facilities for a wide array of FDFs, DC Granules and Pellets (semi-finished), APIs and Intermediates, and more.

CALYX is an Active Pharmaceutical Ingredient and Intermediate manufacturer successfully inspected by the regulatory agencies of USFDA, EDQM, WHO Geneva and other accreditations for the manufacturing site located at Tarapur, Maharashtra (India).

Zhejiang Medicine currently has nine major subsidiaries, including Xinchang Pharmaceutical Factory, Vitamin Factory, Changhai Biological Company, Zhejiang Health Creation Biotechnology Co., Ltd., Zhejiang LaiYi Medicine Co., Ltd., Zhejiang Novus Pharmaceuticals Co., Ltd., Zhejiang Changhai Pharmaceuticals Co., Ltd., Shanghai Vital Health Management Co., Ltd., NovoCodex Biopharmaceuticals. Co., Ltd., and two research units, the Pharmaceutical Industry Research Institute and the Shanghai Laiyi Biopharmaceutical R&D Center. The company has more than 6,800 employees, including more than 2,500 professional and technical personnel, who account for more than 37% of the company’s total number of employees.

Our company is engaged in the manufacturing of active pharmaceutical ingredients in Russia and is in the process of finalizing the construction of our facility in Austria dedicated to the production of pharmaceutical drugs. The active pharmaceutical ingredients are derived using the purest fresh water sourced from a reservoir and powered by sustainable electricity from the Novosibirsk hydroelectric power station

Chynops Pharma, a company certified with ISO 9001:2015, is located in Ahmedabad, India. We specialize in the export, supply, and trade of a diverse range of products, including APIs, Advanced Drug Intermediates, Impurity Standards, Working Standards, KSMs, Industrial Chemicals, Specialty Chemicals, Excipients, Amino Acids, Vitamins, Minerals, Herbal Extracts, Essential Oils, Prebiotics & Probiotics, Veterinary APIs, Solvents, and more from India. Our dedication extends to providing these products to valued customers in both the domestic and global markets.